Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Pharmacogenomics. 2008 Nov;9(11):1639–1645. doi: 10.2217/14622416.9.11.1639

Figure 2. Principal components analysis of the 270 HapMap individuals.

Figure 2

PC#1 (A-D) and PC#2 versus PC#3 (E-H) across SNPs from (A, E) irinotecan, (B, F) 5-FU, and (C, G) insulin pathway genes and (D, H) 362 randomly chosen SNPs. Full PCA figures are available in Figure 2 of the Supplemental material available at [108].

PC: Principal component; PCA: Principal components analysis.